Investigating how mucin proteins influence lung cancer development

Effects of Polymeric Mucin Expression on Lung Carcinogenesis

NIH-funded research VA Eastern Colorado Health Care System · NIH-10881758

This study is looking at how certain proteins in the lungs might affect the growth of a type of lung cancer called adenocarcinoma, especially in people with a specific gene mutation, to help find new ways to treat this disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Eastern Colorado Health Care System NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-10881758 on NIH RePORTER

What this research studies

This research focuses on understanding the role of specific mucin proteins, MUC5AC and MUC5B, in the development of lung adenocarcinoma (LUAD), a common and aggressive form of lung cancer. The study aims to uncover how these mucins contribute to tumor growth and aggressiveness, particularly in patients with mutations in the KRAS gene. By using mouse models, researchers will explore the effects of these mucins on tumor size and number, as well as the underlying molecular mechanisms involved. This could lead to new insights into potential therapeutic targets for LUAD.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with lung adenocarcinoma, particularly those with KRAS mutations.

Not a fit: Patients with lung cancer types other than adenocarcinoma or those without KRAS mutations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for lung adenocarcinoma, potentially enhancing survival rates for patients.

How similar studies have performed: Previous research has shown promising results in understanding the role of mucins in cancer biology, suggesting that this approach could yield valuable insights.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.